INT-777 prevents cognitive impairment by activating Takeda G protein-coupled receptor 5 (TGR5) and attenuating neuroinflammation via cAMP/ PKA/ CREB signaling axis in a rat model of sepsis.

Abstract

BACKGROUND:

Survivors of sepsis must often endure significant cognitive and behavioral impairments after discharge, but research on the relevant mechanisms and interventions remains lacking. TGR5, a member of the class A GPCR family, plays an important role in many physiological processes, and recent studies have shown that agonists of TGR5 show neuroprotective effects in a variety of neurological disorders. To date, no studies have assessed the effects of TGR5 on neuroinflammatory, cognitive, or behavioral changes in sepsis models.

METHODS:

A total of 267 eight-week-old male Sprague-Dawley rats were used in this study. Sepsis was induced via cecal ligation and puncture (CLP). All animals received volume resuscitation. The rats were given TGR5 CRISPR oligonucleotide intracerebroventricularly 48 h before CLP surgery. INT-777 was administered intranasally 1 h after CLP, and the cAMP inhibitor, SQ22536, was administered intracerebroventricularly 1 h after CLP. Survival rate, bodyweight change, and clinical scores were assessed, and neurobehavioral tests, western blot, and immunofluorescence staining were performed. The cognitive function of rats was measured using the Morris water maze during 15-20 days after CLP.

RESULTS:

The expression of TGR5 in the rat hippocampus was upregulated, and peaked at 3 days after CLP. The survival rate of rats after CLP was less than 50%, and the growth rate, in terms of weight, was significantly decreased. While INT-777 treatment did not improve these changes, the treatment did reduce the clinical scores of rats at 24 h after CLP. On day 15 and later, the surviving mice completed a series of behavioral tests. CLP rats showed spatial and memory deficits and anxiety-like behaviors, but INT-777 treatment significantly improved these effects. Mechanistically, immunofluorescence analysis showed that INT-777 treatment reduced the number of microglia in the hippocampus, neutrophilic infiltration, and the expression of inflammatory factors after CLP in rats. Moreover, INT-777 treatment significantly increased the expression of TGR5, cAMP, p-PKA, and p-CREB, but downregulated the expression of IL-1β, IL-6, and TNF-α. CRISPR-mediated TGR5 knockdown and SQ22536 treatment abolished the neuroprotective effects of TGR5 activation after CLP.

CONCLUSION:

This study demonstrates that INT-777 treatment reduced neuroinflammation and microglial cell activation, but improved cognitive impairment in the experimental sepsis rats. TGR5 has translational potential as a therapeutic target to improve neurological outcomes in sepsis survivors.

• Authors: Peng Jin, Shuixiang Deng, Mi Tian, Cameron Lenahan, Pengju Wei, Yao Wang, Jiaying Tan, Huimei Wen, Feng Zhao, Yanqin Gao, Ye Gong
• Journal: Experimental neurology (Exp Neurol) Vol. 335 Pg. 113504 (01 2021) ISSN: 1090-2430 [Electronic] United States
• PMID: 33058889 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2020 Elsevier Inc. All rights reserved.

Chemical References

• 6alpha-ethyl-23(S)-methylcholic acid
• CREB1 protein, rat
• Cholic Acids
• Cyclic AMP Response Element-Binding Protein
• Cytokines
• Gpbar1 protein, rat
• Nootropic Agents
• Receptors, G-Protein-Coupled
• 9-(tetrahydro-2-furyl)-adenine
• Cyclic AMP
• Cyclic AMP-Dependent Protein Kinases
• Adenine

Topics

• Adenine (analogs & derivatives, pharmacology)
• Animals
• Anxiety (psychology)
• Cholic Acids (therapeutic use)
• Cognitive Dysfunction (drug therapy, etiology, psychology)
• Cyclic AMP (antagonists & inhibitors)
• Cyclic AMP Response Element-Binding Protein
• Cyclic AMP-Dependent Protein Kinases
• Cytokines (biosynthesis)
• Encephalitis (drug therapy, pathology)
• Male
• Maze Learning (drug effects)
• Nootropic Agents (therapeutic use)
• Rats
• Rats, Sprague-Dawley
• Receptors, G-Protein-Coupled (agonists)
• Sepsis (complications, drug therapy, psychology)
• Signal Transduction (drug effects)
• Survival Analysis